← Back to headlines
BridgeBio Stock Rises After Rival Drug Trial Failure
BridgeBio's stock experienced a significant jump following the announcement that a rival company's heart drug failed a crucial clinical trial.
9 Jul, 23:38 — 9 Jul, 23:38
Sources
Showing 1 of 1 sources
